Shamburg News · 8-K filed Nov 9, 2026, 4:11 PM EST
ZeroStack Corp. Agrees to Sell Phatebo GmbH to New Horizon Pharma for €2.15 Million
ZSTK · ZeroStack Corp.
- Material agreement
- Acquisition
- Materiality: medium
On November 3, 2026, ZeroStack Corp. entered into a Share Purchase and Transfer Agreement with New Horizon Pharma B.V. and Phatebo GmbH to sell all outstanding shares of Phatebo, which the Company wholly owns. The aggregate purchase price is €2,150,000. Closing is subject to German foreign direct investment clearance and other customary closing conditions.
Source: SEC EDGAR, Form 8-K, Items 1.01, 9.01, accession 0001062993-26-005837.
Written from the filing by Shamburg Markets. Figures are as reported by the company.